Analgesics in Mexico

Date: October 31, 2017
Pages: 20
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A2762A22EBBEN
Leaflet:

Download PDF Leaflet

In 2017, retail sales of analgesics saw strong current value growth, driven to a great extent by price increases. This was mostly due to inflationary pressures and a weakening local currency. Currency plays a significant role, as most branded analgesics and/or the active ingredients used to manufacture them locally, are imported. Over the forecast period anticipated economic growth below expectation, increasing inflation, may erode consumer purchasing power, and a further deterioration of the ex...

Euromonitor International's Analgesics in Mexico report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Headlines
Prospects
Price Increases Drive the Value of Analgesics in 2017
Private Label and Generics Have A Stronger Presence
Specific Positioning and Combination Products Drive Growth of Branded Analgesics
Competitive Landscape
Generics and Private Label Challenge the Leading OTC Brands
Companies Shift Marketing Efforts From TV Advertising To Points of Sale
Sanofi and Boehringer Ingelheim Finalise A Business Swap in 2017
Category Data
  Table 1 Sales of Analgesics by Category: Value 2012-2017
  Table 2 Sales of Analgesics by Category: % Value Growth 2012-2017
  Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2012-2017
  Table 4 NBO Company Shares of Analgesics: % Value 2013-2017
  Table 5 LBN Brand Shares of Analgesics: % Value 2014-2017
  Table 6 Forecast Sales of Analgesics by Category: Value 2017-2022
  Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2017-2022
Executive Summary
Generics and Private Label Continue Gaining Share
Leading Manufacturers Increasingly Shift Their Marketing Efforts To the Point of Sale
Changing Lifestyles Drive Growth of Consumer Health Products
Health and Wellness Concerns Fuel Innovation
Inflation and Weak Local Currency Impact Prices
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
  Table 9 Life Expectancy at Birth 2012-2017
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2012-2017
  Table 11 Sales of Consumer Health by Category: % Value Growth 2012-2017
  Table 12 NBO Company Shares of Consumer Health: % Value 2013-2017
  Table 13 LBN Brand Shares of Consumer Health: % Value 2014-2017
  Table 14 Distribution of Consumer Health by Format: % Value 2012-2017
  Table 15 Distribution of Consumer Health by Format and Category: % Value 2017
  Table 16 Forecast Sales of Consumer Health by Category: Value 2017-2022
  Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Sources
  Summary 1 Research Sources
Skip to top


OTC Pharmaceuticals in Mexico US$ 350.00 Sep, 2016 · 40 pages
Eye Care in Mexico US$ 990.00 Oct, 2017 · 19 pages
Wound Care in Mexico US$ 900.00 Mar, 2015 · 21 pages

Ask Your Question

Analgesics in Mexico
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: